Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, RE, 42123, Italy
Location status: Recruiting
NCT Number: NCT06994182
European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt actions and recommendations. Employers are important stakeholders, as they can provide emotional and practical support, sustain communication during the entire process, and guarantee a gradual work reintegration. In Italy there is lack of knowledge regarding this topic. Thus, further exploration of Italian employers' perspectives on the RTW of employees with cancer should be performed to comprehend their unknown experiences.
The aim is to explore the perspectives of employers who dealt with the RTW process of employees who received a cancer diagnosis through a qualitative research design.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Reggio Emilia, RE, 42123, Italy
Location status: Recruiting
Data collection will be performed through individual semi-structured interviews. Each interview will last around 60 minutes, and it can be arranged in person or remotely, depending on the participant's preference. Socio-demographic data, expertise of the employer, and company-related data will be collected through a semi-structured interview.
Experiences of employers will be collected through open-ended questions using an interview guide that was written based on the one used by Tiedtke et al., 2017, by adding some questions related to the facilitators and barriers perceived by employers during the sickness absence and RTW of employee with cancer.
The open-ended questions will concern general information about the company, employers' experience after cancer disclosure and during sick leave, employers' experience to sustain the RTW process and the long-term work reintegration, and the influence of the experience on the company.
Each interview will be audio-recorded, transcribed verbatim and analyzed according to the thematic analysis method using an inductive approach with open coding.
Analysis will be iterative and involve multiple researchers to ensure inter-rater reliability of the coding procedure and the methodological rigor of the analysis.
Themes generated will be discussed with Dutch researchers from the Amsterdam University Medical Centers.
Analyses will be carried out at the end of each interview because, based on the themes that will emerge from each interview, we will understand when to stop recruiting.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
Themes describing how employers managed the RTW process of employees with cancer, of their feeling and thoughts, of what actions did they do, and of the relationships and communication with the other members of the company
Time frame: 12 months
Themes describing what employers require to support employees who receive a cancer diagnosis in the RTW process
Time frame: 12 months
Themes describing the facilitators and barriers perceived by employers during the RTW process of employees who received a cancer diagnosis. For this outcome, themes will be classified using the Resource Dependence Institutional Cooperation (RDIC) model, developed by Rijk et al. and adjusted by Greidanus et al. (2018).
Contact information is provided by the study sponsor or research team.
Sara Paltrinieri, PhD, OT
CONTACT
Stefania Costi, PhD, PT
CONTACT
Azienda USL Reggio Emilia - IRCCS
Other Gov
Acronym: employers_2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06834685
Cancer Survivors, Peripheral Neuropathic Pain
Montpellier, France
View Trial DetailsNCT07161713
Cancer Survivors, Cancer Survivorship
Stony Brook, New York, United States
View Trial DetailsNCT07561957
Blood Pressure Control, Cancer Survivors
Dublin, Ireland
View Trial DetailsNCT06904495
Cancer Survivors
Nice, France
View Trial Details